STAT August 5, 2020
Karen Mulligan and Karen Van Nuys

Hopes for a relatively quick return to normalcy are riding high on promising news about Covid-19 vaccines. Nearly 200 vaccines are in development worldwide. And with six of them already being tested in Phase 3 clinical trials, the possibility exists that a vaccine could be ready by the end of the year

But we need to be realistic: A vaccine is not a silver bullet. Even if one (or more) is proven safe and effective, vaccines are notoriously difficult to make and distribute. People will continue to contract the virus because some won’t get vaccinated and because the vaccine may not be effective for everyone, particularly older populations at higher risk for illness and death. The annual flu vaccine, for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
U.S. expands testing for bird flu in dairy cows
Bridging Public Health and Social Movements
Watch: What we know about traces of H5N1 bird flu found in pasteurized milk
A Bird Flu H5N1 Status Report
Hepatitis Kills 3500 People Each Day, Says WHO

Share This Article